#USA #Palo Alto #GenBio AI #Digital Organism #Emma Lundberg

GenBio AI Welcomes Emma Lundberg

GenBio AI, a pioneering organization dedicated to constructing the world's first AI-driven digital organism, is thrilled to announce the addition of Dr. Emma Lundberg as Co-Founder and Chief Scientific Advisor. This strategic appointment signifies a transformative step towards establishing essential data strategies and scientific paradigms within the company.

Dr. Lundberg, celebrated for her exceptional contributions at the intersection of spatial proteomics, bioimaging, and artificial intelligence, is set to lead groundbreaking initiatives aimed at evolving GenBio AI's capabilities. In her own words, "I’m thrilled to join GenBio AI in building the next generation of biology through AI. The chance to train multi-scale and multi-modal computational models at unprecedented scales, allowing for lifecycle simulations at the cellular level, represents a dream come true for any scientist. This pivotal move will critically enhance biomedical research."

Visionary Leadership

Dr. Lundberg is internationally recognized for her innovative work as an Associate Professor at both Stanford University and KTH Royal Institute of Technology in Sweden. Besides her academic roles, she coordinates the Cell Atlas project within the Human Protein Atlas initiative, an extensive campaign focused on understanding the spatial orchestration of human proteins. Her laboratory is noted for making significant strides in the realms of protein dynamics and localization, which form a critical foundation for developing high-resolution virtual cell models and in silico experimentation.

Eric Xing, Co-Founder and Chief Scientist of GenBio AI, conveyed his enthusiasm for this appointment, emphasizing that "Emma's visionary approach to understanding cellular architecture through advanced imaging and AI technologies has revolutionized areas of biomedical research. Her leadership will be paramount as we strive to create the first virtual cell and virtual tissue within the framework of our AI-driven digital organism. This initiative is pivotal in lessening reliance on traditional lab methods and animal testing."

An Advocate for Open Science

Beyond her contributions to academia, Dr. Lundberg is a staunch advocate for open science and public engagement. She has championed various initiatives, including transforming scientific discovery into a gamified experience through citizen science. Her advisory roles have been significant in global entities, such as the Human Proteome Organization and the Chan Zuckerberg Initiative's AI Virtual Cell project.

The official incorporation of Dr. Lundberg into GenBio AI's founding team not only embodies a significant milestone in shaping the company's scientific trajectory but also reflects its commitment to advancing biomedicine. With her unmatched expertise and entrepreneurial spirit, GenBio AI stands at the forefront of constructing an AI digital organism poised to revolutionize the field of life sciences.

About GenBio AI

GenBio AI aims to innovate with the world’s first AI-driven Digital Organism (AIDO). By developing a series of multiscale foundation models capable of simulating, predicting, and programming biological systems at diverse levels, GenBio is on a mission to propel advancements in drug design and biomedical research. Headquartered in Palo Alto, with additional offices in Abu Dhabi and Paris, the organization is comprised of leading scientists from esteemed institutions, including Carnegie Mellon University and Stanford University, and is backed by prominent investors, making it a significant player in the future of life sciences.